Cefepime dihydrochloride monohydrate CAS:123171-59-5
Cefepime Dihydrochloride Monohydrate waxaa badanaa loo isticmaalaa dhaqanka caafimaadka si wax looga qabto caabuqyada bakteeriyada daran sida oof-wareenka isbitaalka laga qaado, sepsis, caabuqyada kaadi mareenka, caabuqyada caloosha gudaheeda, iyo qandhada neerfaha. Hawlgalkeeda ballaaran, oo ay ku jiraan dhaqdhaqaaqa ka dhanka ah noolaha daawada badan u adkaysta, ayaa ka dhigaya ikhtiyaar qiimo leh oo lagu daweeyo caabuqyada adag ee bukaanada isbitaalka la dhigay. Bixiyeyaasha daryeelka caafimaadku waxay si taxaddar leh u go'aamiyaan qiyaasta ku habboon, inta jeer, iyo muddada daaweynta cefepime dihydrochloride monohydrate iyadoo lagu saleynayo caabuqa gaarka ah, jeermiska la aqoonsaday ama laga shakisan yahay, iyo arrimaha bukaanka gaarka ah. Daaweynta xididka waxay u oggolaanaysaa in si degdeg ah oo sax ah loo keeno daawada, taasoo sahlaysa isticmaalkeeda bukaanada aadka u xanuunsan. La socodka dhow ee waxyeellooyinka suurtagalka ah, sida falcelinta xasaasiyadda, cilladda kelyaha, ama saameynta habdhiska neerfaha dhexe, waa lama huraan inta lagu jiro daaweynta cefepime dihydrochloride monohydrate. U hoggaansanaanta nidaamka daaweynta ee loo qoray iyo dhammaystirka koorsada buuxda ee antibiyootikada ayaa muhiim u ah si loo hubiyo in la ciribtiro wakiilka faafa iyo in la yareeyo khatarta caabuqyada soo noqnoqda ama horumarinta iska caabbinta antibiyootikada. Iyadoo la raacayo hababka ugu wanaagsan ee qorista iyo isticmaalka cefepime dihydrochloride monohydrate, xirfadlayaasha daryeelka caafimaadku waxay higsanayaan inay si wax ku ool ah u maareeyaan caabuqyada bakteeriyada daran iyagoo yareynaya soo ifbaxa noocyada iska caabbinta iyo kor u qaadista natiijooyinka caafimaad ee ugu wanaagsan ee bukaanada isbitaalka la dhigay.
| Halabuurka | C19H28Cl2N6O6S2 |
| Baaritaan | 99% |
| Muuqaalka | budo cad |
| Lambarka CAS. | 123171-59-5 |
| Baakad | Yar iyo weyn |
| Muddada Khafiska | 2 sano |
| Kaydinta | Ku kaydi meel qabow oo qalalan |
| Shahaadada | ISO. |








